BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 6
• 7
• 8
• 9
• 10
• 13
• 14
• 15
• 16
• 17
• 18
• 20
• 21
• 22
• 27
• 28
• 29
• 30

• Policy

  Pozen, Inc. Submits Full Response To FDA Approvable Letter For Trexima(TM)

  November 9, 2006

   · 

  1 min read
• Business

  Genitope Corporation Announces Financial Results For Third Quarter And Nine Months Ended September 30, 2006

  November 9, 2006

   · 

  1 min read
• Biovail Corporation Declares Quarterly Dividend

  November 9, 2006

   · 

  1 min read
• Drug Development

  Osiris Therapeutics, Inc. Reports Positive Phase II Results Using PROCHYMAL(TM) For The Treatment Of Acute Graft Vs. Host Disease

  November 9, 2006

   · 

  1 min read
• Elan Corporation PLC Announces Proposed Offering Of Senior Notes

  November 9, 2006

   · 

  1 min read
• Business

  Progenics Pharmaceuticals, Inc. Reports Third Quarter 2006 Results

  November 9, 2006

   · 

  1 min read
• Business

  IMPAX Laboratories, Inc. Appoints Grant Thornton As Principal Accountant

  November 9, 2006

   · 

  1 min read
• Business

  Biovail Corporation Reports Third-Quarter 2006 Financial Results

  November 9, 2006

   · 

  1 min read
• BioCapital

  Heartscape Technologies Enrolls First Patient In OCCULT-MI Clinical Trial Using Its PRIME ECG(R) System

  November 9, 2006

   · 

  1 min read
• Business

  deCODE genetics, Inc. Announces Third Quarter 2006 Financial Results

  November 9, 2006

   · 

  11 min read